These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
342 related articles for article (PubMed ID: 7622822)
1. Comparison of compliance between serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. Montgomery SA; Kasper S Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():33-40. PubMed ID: 7622822 [TBL] [Abstract][Full Text] [Related]
2. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Montgomery SA; Henry J; McDonald G; Dinan T; Lader M; Hindmarch I; Clare A; Nutt D Int Clin Psychopharmacol; 1994; 9(1):47-53. PubMed ID: 8195583 [TBL] [Abstract][Full Text] [Related]
3. WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs). Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2007 Jul; (3):CD002791. PubMed ID: 17636706 [TBL] [Abstract][Full Text] [Related]
4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability. Anderson IM J Affect Disord; 2000 Apr; 58(1):19-36. PubMed ID: 10760555 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of tricyclic antidepressants and SSRIs compared with placebo for treatment of depression in primary care: a meta-analysis. Arroll B; Macgillivray S; Ogston S; Reid I; Sullivan F; Williams B; Crombie I Ann Fam Med; 2005; 3(5):449-56. PubMed ID: 16189062 [TBL] [Abstract][Full Text] [Related]
6. SSRIS versus tricyclic antidepressants in depressed inpatients: a meta-analysis of efficacy and tolerability. Anderson IM Depress Anxiety; 1998; 7 Suppl 1():11-7. PubMed ID: 9597346 [TBL] [Abstract][Full Text] [Related]
7. Direct comparison of tricyclic and serotonin-reuptake inhibitor antidepressants in randomized head-to-head trials in acute major depression: Systematic review and meta-analysis. Undurraga J; Baldessarini RJ J Psychopharmacol; 2017 Sep; 31(9):1184-1189. PubMed ID: 28633600 [TBL] [Abstract][Full Text] [Related]
8. A comparison of side effects of selective serotonin reuptake inhibitors and tricyclic antidepressants in older depressed patients: a meta-analysis. Wilson K; Mottram P Int J Geriatr Psychiatry; 2004 Aug; 19(8):754-62. PubMed ID: 15290699 [TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors and tricyclic antidepressants in the acute treatment of chronic depression and dysthymia: a systematic review and meta-analysis. von Wolff A; Hölzel LP; Westphal A; Härter M; Kriston L J Affect Disord; 2013 Jan; 144(1-2):7-15. PubMed ID: 22963896 [TBL] [Abstract][Full Text] [Related]
10. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Barbui C; Hotopf M; Freemantle N; Boynton J; Churchill R; Eccles MP; Geddes JR; Hardy R; Lewis G; Mason JM Cochrane Database Syst Rev; 2000; (4):CD002791. PubMed ID: 11034764 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease. Pollok J; van Agteren JE; Carson-Chahhoud KV Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis. Liu J; Dong J; Wang L; Su Y; Yan P; Sun S PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview. Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236 [TBL] [Abstract][Full Text] [Related]
15. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Anderson IM; Tomenson BM BMJ; 1995 Jun; 310(6992):1433-8. PubMed ID: 7613276 [TBL] [Abstract][Full Text] [Related]
16. Does the use of SSRIs reduce medical care utilization and expenditures? Chung S J Ment Health Policy Econ; 2005 Sep; 8(3):119-29. PubMed ID: 16278500 [TBL] [Abstract][Full Text] [Related]
17. Discontinuation rates of SSRIs and tricyclic antidepressants: a meta-analysis and investigation of heterogeneity. Hotopf M; Hardy R; Lewis G Br J Psychiatry; 1997 Feb; 170():120-7. PubMed ID: 9093499 [TBL] [Abstract][Full Text] [Related]
18. Selective serotonin reuptake inhibitors versus tricyclic antidepressants in young patients: a meta-analysis of efficacy and acceptability. Qin B; Zhang Y; Zhou X; Cheng P; Liu Y; Chen J; Fu Y; Luo Q; Xie P Clin Ther; 2014 Jul; 36(7):1087-1095.e4. PubMed ID: 24998011 [TBL] [Abstract][Full Text] [Related]
19. Fluoxetine versus other types of pharmacotherapy for depression. Cipriani A; Brambilla P; Furukawa T; Geddes J; Gregis M; Hotopf M; Malvini L; Barbui C Cochrane Database Syst Rev; 2005 Oct; (4):CD004185. PubMed ID: 16235353 [TBL] [Abstract][Full Text] [Related]
20. Response and discontinuation rates of newer antidepressants: a meta-analysis of randomized controlled trials in treating depression. Srisurapanont M J Med Assoc Thai; 1998 Jun; 81(6):387-92. PubMed ID: 9676069 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]